Cargando…

A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?

BACKGROUND: The incidence of Hodgkin lymphoma (HL) among HIV-infected individuals remains unchanged since the introduction of combination antiretroviral therapy (cART). Recent epidemiological data suggest that CD4 count decline over a year is associated with subsequent diagnosis of HL. In an era of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ravindra K., Marks, Michael, Edwards, Simon G., Smith, Katie, Fletcher, Katie, Lee, Siow-Ming, Ramsay, Alan, Copas, Andrew J., Miller, Robert F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913599/
https://www.ncbi.nlm.nih.gov/pubmed/24504076
http://dx.doi.org/10.1371/journal.pone.0087442
_version_ 1782302252908675072
author Gupta, Ravindra K.
Marks, Michael
Edwards, Simon G.
Smith, Katie
Fletcher, Katie
Lee, Siow-Ming
Ramsay, Alan
Copas, Andrew J.
Miller, Robert F.
author_facet Gupta, Ravindra K.
Marks, Michael
Edwards, Simon G.
Smith, Katie
Fletcher, Katie
Lee, Siow-Ming
Ramsay, Alan
Copas, Andrew J.
Miller, Robert F.
author_sort Gupta, Ravindra K.
collection PubMed
description BACKGROUND: The incidence of Hodgkin lymphoma (HL) among HIV-infected individuals remains unchanged since the introduction of combination antiretroviral therapy (cART). Recent epidemiological data suggest that CD4 count decline over a year is associated with subsequent diagnosis of HL. In an era of economic austerity monitoring the efficacy of cART by CD4 counts may no longer be required where CD4 count>350 cells/µl and viral load is suppressed (<50 copies/ml). METHODS: We sought to establish among our HIV outpatient cohort whether a CD4 count decline prior to diagnosis of HL, whether any decline was greater than in patients without the diagnosis, and also whether other clinical or biochemical indices were reliably associated with the diagnosis. RESULTS: Twenty-nine patients with a diagnosis of HL were identified. Among 15 individuals on cART with viral load <50 copies/ml the change in CD4 over 12 months preceding diagnosis of HL was −82 cells/µl (95% CI −163 to −3; p = 0.04). Among 18 matched controls the mean change was +5 cells/µl, 95% CI −70 to 80, p = 0.89). The decline in CD4 over the previous 6–12 months was somewhat greater in cases than controls (mean difference in change −55 cells/µl, 95% CI −151 to 39; p = 0.25). In 26 (90%) patients B symptoms had been present for a median of three months (range one–12) before diagnosis of HL. CONCLUSIONS: The CD4 count decline in the 12 months prior to diagnosis of Hodgkin lymphoma among HIV-infected individuals with VL<50 copies/ml on cART was not significantly different from that seen in other fully virologically suppressed individuals in receipt of cART and who did not develop HL. All those who developed HL had B symptoms and/or new palpable lymphadenopathy, suggesting that CD4 count monitoring if performed less frequently, or not at all, among those virologically suppressed individuals with CD4 counts >350 may not have delayed diagnosis.
format Online
Article
Text
id pubmed-3913599
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39135992014-02-06 A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? Gupta, Ravindra K. Marks, Michael Edwards, Simon G. Smith, Katie Fletcher, Katie Lee, Siow-Ming Ramsay, Alan Copas, Andrew J. Miller, Robert F. PLoS One Research Article BACKGROUND: The incidence of Hodgkin lymphoma (HL) among HIV-infected individuals remains unchanged since the introduction of combination antiretroviral therapy (cART). Recent epidemiological data suggest that CD4 count decline over a year is associated with subsequent diagnosis of HL. In an era of economic austerity monitoring the efficacy of cART by CD4 counts may no longer be required where CD4 count>350 cells/µl and viral load is suppressed (<50 copies/ml). METHODS: We sought to establish among our HIV outpatient cohort whether a CD4 count decline prior to diagnosis of HL, whether any decline was greater than in patients without the diagnosis, and also whether other clinical or biochemical indices were reliably associated with the diagnosis. RESULTS: Twenty-nine patients with a diagnosis of HL were identified. Among 15 individuals on cART with viral load <50 copies/ml the change in CD4 over 12 months preceding diagnosis of HL was −82 cells/µl (95% CI −163 to −3; p = 0.04). Among 18 matched controls the mean change was +5 cells/µl, 95% CI −70 to 80, p = 0.89). The decline in CD4 over the previous 6–12 months was somewhat greater in cases than controls (mean difference in change −55 cells/µl, 95% CI −151 to 39; p = 0.25). In 26 (90%) patients B symptoms had been present for a median of three months (range one–12) before diagnosis of HL. CONCLUSIONS: The CD4 count decline in the 12 months prior to diagnosis of Hodgkin lymphoma among HIV-infected individuals with VL<50 copies/ml on cART was not significantly different from that seen in other fully virologically suppressed individuals in receipt of cART and who did not develop HL. All those who developed HL had B symptoms and/or new palpable lymphadenopathy, suggesting that CD4 count monitoring if performed less frequently, or not at all, among those virologically suppressed individuals with CD4 counts >350 may not have delayed diagnosis. Public Library of Science 2014-02-04 /pmc/articles/PMC3913599/ /pubmed/24504076 http://dx.doi.org/10.1371/journal.pone.0087442 Text en © 2014 Gupta et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gupta, Ravindra K.
Marks, Michael
Edwards, Simon G.
Smith, Katie
Fletcher, Katie
Lee, Siow-Ming
Ramsay, Alan
Copas, Andrew J.
Miller, Robert F.
A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?
title A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?
title_full A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?
title_fullStr A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?
title_full_unstemmed A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?
title_short A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?
title_sort declining cd4 count and diagnosis of hiv-associated hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913599/
https://www.ncbi.nlm.nih.gov/pubmed/24504076
http://dx.doi.org/10.1371/journal.pone.0087442
work_keys_str_mv AT guptaravindrak adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT marksmichael adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT edwardssimong adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT smithkatie adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT fletcherkatie adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT leesiowming adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT ramsayalan adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT copasandrewj adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT millerrobertf adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT guptaravindrak decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT marksmichael decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT edwardssimong decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT smithkatie decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT fletcherkatie decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT leesiowming decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT ramsayalan decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT copasandrewj decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis
AT millerrobertf decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis